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Using unpublished data from an original study by Turner et al. (2010a), the 
relationship between first morning void (FMV) and 24-hour urine collections was 
examined in UK adults to determine if FMV collections provide a reasonable estimate of 
DON intake compared to 24-hour collections. The intraclass correlation coefficient (ICC) 
was computed to evaluate variability in DON concentrations and generalized estimating 
equation (GEE) models were used to assess the relationship between collection types. 
Greater between-person variability was observed in 24-hour collections, unadjusted and 
adjusted for creatinine (ICC=0.78 and 0.56, respectively). GEE models suggest urinary 
DON concentrations in FMV collections were strongly correlated with 24-hour 
collections (r=0.78, p<0.0001), meaning FMV collections may provide just as reasonable 
an estimate of DON intake compared to 24-hour collections when adjusting for age, sex, 
and BMI. These results strengthen the methodology behind exposure biomarkers and 
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Chapter 1: Introduction 
Rationale and Research Questions 
 
Deoxynivalenol (DON) is a naturally occurring mycotoxin that predominantly 
contaminates wheat, maize, and barley, and causes adverse health effects in both animals 
and humans (Pestka, 2007). The development of analytical tools to measure DON and its 
metabolites have allowed the relationship between exposure to DON and the urinary 
measure to be examined. Urinary DON was strongly correlated with DON intake and has 
now been used as a validated exposure biomarker (Turner et al., 2010a). Exposure 
assessment using urinary biomarkers is best conducted using 24-hour urine collections. In 
many instances, these remain complex and unreliable to collect in comparison to first 
morning void (FMV) or spot urine collections. However, it is unclear if FMV collections 
provide a reasonable estimate of exposure to DON. 
Using unpublished data from the same study by Turner et al. (2010a), objectives 
of this thesis are to: 1) determine the correlation between FMV and 24-hour urine 
collections within a given study population, and 2) better understand and describe the 
strength of these measures in estimating DON exposure. The results of this study aim to 
strengthen the methodology behind exposure biomarkers and urinary assays when 
estimating DON intake. 
Literature Review 
Mycotoxins 
Mycotoxins are secondary metabolites of certain fungi that produce toxic effects 
in both animals and humans. Although similar toxic episodes were documented as far 




programs established after a major unexplained toxicosis event occurred in farm animals 
in England in the 1960s (Peraica et al., 1999). Over the course of a few months, what 
came to be known as “turkey X disease” was responsible for killing nearly 100,000 
turkeys that consumed an unknown contaminant, later identified as a mycotoxin, in 
contaminated Brazilian peanut meal (de Iongh et al., 1962). 
There are many mycotoxins, but only a few are of public health concern. The five 
major groups of foodborne mycotoxins include trichothecenes, zearalenone, ochratoxin, 
fumonisins, and aflatoxins. Trichothecenes include deoxynivalenol (DON), nivalenol, 
diacetoxyscirpenol, and T-2 toxin. Mycotoxin contamination of food and feeds, mostly 
grains, occurs in both industrialized and developing countries, flourishing where 
environmental conditions favor mycotoxin growth. Certain mycotoxins such as aflatoxins 
and fumonisins flourish in hot and humid climates, whereas trichothecenes and 
ochratoxins flourish in more temperate regions. Industrialized countries are often 
protected from mycotoxin exposure because of improved farming and storage practices, 
increased regulation, economic capacity to remove highly contaminated crops from the 
food chain, and greater dietary diversity, which limits mycotoxin exposure and results in 
better-nourished populations. By comparison, many developing countries have greater 
risks following exposure due to dietary monotony and malnutrition. Typically, few 
regulations exist to protect such populations (Bennett & Klich, 2003).  
Deoxynivalenol and Health 
 
Trichothecene contamination is becoming an increasingly common problem due 
to expanded use of no-till farming practices and changing climate patterns (Pestka, 2007). 




the Fusarium species of fungi and can contaminate crops in the field and during storage 
processes (Peraica et al., 1999; Pestka, 2010). An example of a Fusarium species is F. 
graminearum, which is considered a field fungus because it invades crops before harvest. 
The other Fusarium species, F. crookwellense and F. clumorum, invade after harvest and 
are referred to as storage fungi (Food and Agriculture Organization of the United 
Nations, 1997). DON frequently affects commodities like wheat, maize, and barley, and 
rarely affects oats, rice, and other grains. Occurrences are common in temperate climates 
in most regions of the world (Zain, 2011). In 2001, the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) surveyed food consumption data and dietary 
intake estimates among five regional diets. Estimates were highest in the Middle East 
(2.4 µg/kg bw/day), followed by Far Eastern (1.6 µg/kg bw/day), European (1.4 µg/kg 
bw/day), Latin America (1.2 µg/kg bw/day), and African (0.78 µg/kg bw/day) (Canady et 
al., 2001).  
 Adverse health impacts may occur after consumption of DON-contaminated 
foods. Other less likely exposure routes include skin contact with molded crops and 
inhalation of mycotoxin spores. All animal species evaluated to date are susceptible to 
DON, but sensitivity is ranked in the order of pigs being most susceptible, followed by 
mice, rats, and poultry and ruminants being relatively resistant (Pestka, 2007; Prelusky et 
al., 1994; Zain, 2011). Differences in toxicokinetics (metabolism, absorption, 
distribution, and elimination) may account for the differences seen across animal species. 
The severity of health effects depends on exposure frequency, exposure duration, the 
exposed subject’s age and health, as well as any synergistic effects the mycotoxin may 




Evidence from animal studies show that acute and extremely high DON exposure 
can result in abdominal pain, diarrhea, vomiting (pigs only), and even shock-like death or 
tissue injury, while low DON doses typically just cause vomiting (pigs only) (Pestka, 
2007, 2010). Both short-term and long-term exposure can lead to immune system 
suppression, reduced mean daily food consumption, mean body weight gain, and total 
body weight (Iverson et al., 1995; Sobrova et al., 2010). Impaired reproduction and 
development resulting from maternal toxicity has also been observed in rats and mice 
(Bennett & Klich, 2003; Pestka, 2010; Sobrova et al., 2010). No Observed Adverse 
Effect Levels (NOAELs) range from 0.04-0.375 mg/kg bw/day (European Commission 
Scientific Committee on Food, 1999). DON elicits these responses by inducing ribotoxic 
stress, which disrupts macromolecule synthesis, cell signaling, differentiation, 
proliferation, and death (Pestka, 2010). 
There is historical evidence suggesting that DON causes acute human illness. 
Between 1946 and 1987, large-scale human toxicosis events were documented in Japan, 
Korea, China, and India (Pestka, 2010; Zain, 2011). Thousands of people exhibited 
gastroenteritis with symptoms like nausea, diarrhea, and vomiting after consuming 
Fusarium-contaminated foods. Other documented adverse health impacts include 
abdominal pain, headache, dizziness, and fever (Sobrova et al., 2010; Zain, 2011). 
Although primate or human studies on DON-induced health effects have not been 
reported to date, it is not unreasonable to assume that humans are sensitive to DON. In 
vitro studies using various human cells resulted in impairment of immune function, as 
well as decreases in cell proliferation and cellular defense, which closely resembles the 




carcinogenic and/or mutagenic properties have been observed from DON contamination. 
The International Agency for Research on Cancer (IARC) classified DON as a Group 3 
carcinogen in 1993, meaning it is “not classifiable as to its carcinogenicity to humans” 
due to inadequate evidence in experimental animal studies (International Agency for 
Research on Cancer, 1993). More research must be done to validate DON’s effects in 
humans. 
Advisory limits were set in place to limit exposure to DON. The EU established 
regulations in 2005 for unprocessed wheat (1,750 ppb), cereals (1,250 ppb), flour and 
pasta (750 ppb), breads (500 ppb), and processed instant foods (200 ppb) (European 
Commission, 2005). In comparison to the current FDA advisory level of 1,000 ppb in 
finished wheat products and 5,000-30,000 ppb in grains and grain byproducts for animal 
feed (depending on the species), the EU regulations are relatively more conservative 
(Food and Drug Administration, 2010). This conservative approach may have limitations 
for other countries because DON is rapidly metabolized, does not accumulate in tissues, 
and flourishes depending on the climate (Pestka, 2010). These regulations are not 
generalizable to populations with varying diets and countries with fluctuating climates. 
Deoxynivalenol Biomarkers and Urine Collection Methods 
Traditional mycotoxin detection methods are based off of either reference 
methods for quantitative analysis or rapid methods for first-level screening of numerous 
samples (Anfossi et al., 2016). Thin-layer chromatography (TLC) was the first method 
used for quantitative analysis of mycotoxins. In the developed world, TLC has been 
phased out and replaced with gas chromatography (GC) and liquid chromatography (LC). 




the highest sensitivity, which then became coupled to ultraviolet, fluorescence, or mass 
spectrometric (MS) detection. Today, the preferred method for mycotoxin detection is 
LC-MS because not only is it extremely sensitive, but it can determine over 100 
mycotoxins in a single run, and can also detect mycotoxins simultaneously with other 
environmental contaminants (Shephard, 2016). 
 For first-level screening, immunochemical-based methods are preferred for their 
simplicity, cost-effectiveness, sensitivity, and selectivity. Enzyme-linked immunosorbent 
assay (ELISA) kits are commercially available for all regulated mycotoxins, and 
immunochromatograpic test (ICT) technology allows for their visual detection and semi-
quantification (Anfossi et al., 2016). An issue surrounding ELISA is the possible 
response of a structurally related form of the analyzed mycotoxin rather than a single 
chemical compound (Shephard, 2016). This has been found to be a particular problem for 
DON analysis (Zachariasova et al., 2008). 
 Exposure assessment based on dietary analysis has always been problematic due 
to heterogeneous DON contamination of food items, but biological measures, referred to 
as biomarkers, have tremendously improved this assessment process. In 2003, the first 
urinary assay for DON was confirmed using immunoaffinity enrichment, and 13C15-DON 
was then used as an internal standard for LC-MS detection methods (Meky et al., 2003; 
Turner et al., 2008a; Turner et al., 2008b). This methodology is robust with high 
specificity and sensitivity, incorporating an internal standard that allows adjustment for 
recovery. 
Investigators typically collect spot (at any convenient time), FMV, or 24-hour 




often the easiest to collect but the least accurate, as they may represent a limited exposure 
window. When comparing FMV collections versus 24-hour collections, FMV collections 
provide a time-average for metabolite spikes that occur over a larger window of 
exposure, biotransformation, and excretion. Also, FMV collections are less affected by 
hydration/physical status. On the other hand, 24-hour collections tend to be most 
accurate, providing a time-average for exposure and metabolite spikes that occur over a 
24-hour period. 24-hour collections provide the highest-level of sensitivity when 
assessing very low levels of metabolites, but in many instances, they remain complex and 
unreliable to collect in comparison to FMV or spot collections. This unreliability stems 
from the fact that 24-hour collections are more expensive and require participant 
diligence. It is not uncommon that an individual will forget to provide a urine sample 
during the 24-hour period. Considering all of this, it is unclear if FMV collections 







Chapter 2: Method 
Study Design 
 
 The original longitudinal study by Turner at al. (2010a) examined the relationship 
between DON intake and FMV urinary DON over 12 days in 35 adult volunteers from 
the University of Leeds, UK to validate the latter as a biomarker of human exposure 
(Turner et al., 2010a). FMV samples were collected during a period of normal diet (eight 
days) and during a period of either a wheat-restriction intervention diet or a partial wheat-
restriction intervention diet (both four days). During the wheat-restriction intervention 
diet, 10 volunteers were expected to avoid all wheat and corn commodities, whereas the 
partial wheat-restriction intervention diet allowed bread only for the remaining 25 
volunteers. 
Validated food diaries were kept for volunteers to document the amount and types 
of foods eaten prior to urination. If a volunteer during the partial wheat-restriction 
intervention diet consumed a certain amount of bread, the volunteer was required to cut a 
representative slice of bread to be sent for DON analysis. Thus, for each day, the urine 
sample was paired with the dietary information from the previous day. Measurements of 
urinary DON followed the methods set forth by Turner and colleagues, informed consent 
was received from all volunteers, and ethical approval was obtained from the Leeds 
Teaching Hospitals NHS Trust Research Ethics Committee (Turner et al., 2008b, 2010b). 
Results of the original longitudinal study were published and a strong correlation between 
DON intake and the urinary biomarker was observed (adjusted r2=0.83, p<0.001) in 




 As provided by the principal investigator of the original study, there exists 
unpublished data containing urinary FMV & 24-hour DON measurements from 13 adult 
volunteers from the University of Leeds, UK. Following the same duration of normal 
dieting (eight days), 12 volunteers were subject to the partial-wheat restriction 
intervention diet and one volunteer participated in the full wheat-restriction intervention 
diet (both four days). Each volunteer provided two urine samples for both the FMV and 
24-hour collections. Just like the original study design, food diaries were kept, 
representative bread slices were collected for DON analysis, and urinary DON 
measurements followed methods set forth by Turner and colleagues (Turner et al., 2008b, 
2010b). The University of Maryland Institutional Review Board determined that this 
thesis did not meet the definition of human subjects research since the data/specimens 
were collected in 2007, no further data collection was required, and I did not have access 
to identifiable subject information. 
Data Analysis 
 
Using Statistical Analysis Software (SAS) University Edition, normality was first 
assessed. After looking at all kurtoses and scatterplots, log-transformation was 
determined unnecessary for these comparisons, as most variables were closer to normal 
prior to log-transformation. Then, descriptive statistics were summarized for both the 
study population and outcome variables (unadjusted DON and creatinine-adjusted DON) 
by collection type (FMV vs. 24-hour). 
Since repeated measures were taken on different days for each subject, the 
intraclass correlation coefficient (ICC) was calculated using mixed effects models. The 




concentrations (unadjusted and adjusted for creatinine). An ICC > 0.75 represents 
excellent reproducibility, between 0.4 and 0.75 represents fair to good reproducibility, 
and < 0.4 represents modest to poor reproducibility.  
Generalized estimating equation (GEE) models were used to evaluate the 
correspondence between FMV collections and 24-hour collections, using urinary 24-hour 
DON as the outcome variable and urinary FMV DON as the predictor variable, all 
adjusted for age, sex, and BMI. Analyses were done using three separate models: Model 
1) using unadjusted DON as the outcome variable while keeping all predictors the same, 
Model 2) using unadjusted DON as the outcome variable while adding creatinine as a 
predictor, and Model 3) adjusting for creatinine in the outcome variable while keeping all 
predictors the same. 
Pearson correlation coefficients were also computed to measure strength of the 
relationship between FMV and 24-hour collections. These same comparisons were done 
on log10-transformed data because creatinine-adjusted FMV collections exhibited closer 






Chapter 3: Results	  
 
Among the 13 subjects (8 male, 5 female) in the study, the mean age was 36 years 
(range 23 – 50) and the mean BMI was 25.2 (range 20.2 – 34.1), as seen in Table 1. Table 
1 also displays total mean measurements for the amount of bread consumed (g) as 
documented in the food diaries, DON (µg/day) from representative bread slices, and 
urinary DON intake from bread (ng/kg bw), as well as these measurements when divided 
between the first and second sample. All of these measurements are based off of the 
previous day’s (24-hours) bread consumption.	  A higher mean bread consumption and 
mean DON intake from bread was observed in the second sample compared to the first 
sample (Mean ± SD: 148 g (93)  vs. 136 g (76) and 179 ng/kg bw (160) vs. 154 ng/kg bw 
(114), respectively), but not for DON from bread, which was higher in the first sample 
compared to the second sample (Mean ± SD: 19.7 µg/day (27.8) vs. 13.0 µg/day (11.0)). 
There was no statistically significant difference  among these measures (p>0.05). 
Table 2 displays descriptive statistics for the DON outcome variables (unadjusted 
and adjusted for creatinine) separated into FMV and 24-hour collections. For FMV 
collections, the mean urinary DON concentration (ng/ml) was 11.0 ng/ml (SD: 9.3) with 
a max of 32.8 ng/ml. When adjusted for creatinine (ng/mg), the mean was 9.2 ng/mg 
(SD: 7.1) with a max of 32.4 ng/mg. Among the 24-hour collections, the mean urinary 
DON concentration was 11.5 ng/ml (SD: 11.7) with a max of 41.0 ng/ml. When adjusted 
for creatinine, the mean was 10.0 ng/mg (SD: 6.0) with a max of 21.4 ng/mg. Compared 
to the 24-hour collections, FMV measurements were all slightly lower. 
Results of the ICC computations are displayed in Table 3, unadjusted and 




unadjusted and -0.30 when adjusted for creatinine. Typically, negative values are not 
reported for ICCs, but after much trouble shooting, a positive value could not be 
obtained. According to Taylor (2009), “negative estimates are possible and can be 
interpreted as indicating that the true ICC is low.” Essentially, “two members chosen 
randomly from any class vary almost as much as any two randomly chosen members of 
the whole population” (Taylor, 2009). These negative values can also be driven by the 
fact that there exists a large exposure/intake difference between the first and second 
samples. For example, a measurement from the second sample may contain DON 
remaining from the first sample if the exposure/intake was large enough. This depends on 
exposure/intake amount, individual kinetic clearance, and time of exposure versus time of 
urinary collection. By comparison, 24-hour collections resulted in an ICC of 0.78 
unadjusted and 0.56 when adjusted for creatinine. This means that 78% variability in 
unadjusted 24-hour DON measurements is due to between-person variability, while 22% 
is due to within-person variability. For creatinine-adjusted 24-hour DON, 56% variability 
is due to between-person variability and 44% is due to within-person variability. 
Table 4a presents results of the GEE models examining the relationship between 
FMV collections and 24-hour collections (adjusted for age, sex, and BMI). For each 
model (using unadjusted DON as the outcome variable while keeping all predictors the 
same, using unadjusted DON as the outcome variable while adding creatinine as a 
predictor, and adjusting for creatinine in the outcome variable while keeping all 
predictors the same), the beta coefficients (β) show a small increase (0.2, 0.1, and 0.2, 
respectively) for every unit increase of the outcome variable. The Pearson correlation 




(p=0.0143), respectively. This indicates that all models possess statistically significant, 
and moderate to strong correlations. Using log-transformed data (Table 4b), the beta 
coefficients (β) show a larger increase (0.4, 0.4, and 0.5, respectively) for every unit 
increase of the outcome variable. The Pearson correlation coefficient (r) for all models 
was 0.78 (p<0.0001), indicating that the log-transformed models exhibit even stronger 







Chapter 4: Conclusion	  
Mycotoxin contamination occurs worldwide, with nearly 25% of agricultural 
commodities affected (Turner et al., 2010a). Results of an assessment of dietary intake by 
populations of EU member states show that average level intakes for the population as 
well as for adults are low and do not exceed 46.1% of the recommended TDI of 1 µg/kg 
bw/day for DON, but due to DON’s resistance and growth in temperate regions, DON 
exposure is expected to increase in the UK (SCOOP, 2003). Additionally, biomarker data 
is suggestive that 5-10% of EU adults are exceeding the recommended TDI, and this may 
be predicted to be higher in infants and young children (Turner et al., 2012). There is a 
general lack of understanding regarding how DON health effects in animals translates to 
humans, but the use of urinary biomarkers has greatly improved DON exposure 
assessment (Turner et al., 2008a). Results of the original longitudinal study by Turner et 
al. (2010a) showed a strong correlation between DON intake and the urinary biomarker 
observed (adjusted r2=0.83, p<0.001) in models adjusting for age, sex, and BMI. Still, it 
remained unclear which type of urinary collection best measured DON intake. 
Using unpublished data from that original study, this study aimed to determine the 
correlation between FMV and 24-hour urine collections within a small subset of the 
original study population, and to better understand and describe the strength of these 
measures in estimating DON exposure. Results of this study show that urinary DON 
concentrations in FMV collections are strongly correlated with levels in same-day 24-
hour collections. Greater between-person variability than within-person variability was 
observed in urinary 24-hour DON collections. The unadjusted ICC (0.78) indicated 




reproducibility. Thus, 22%-44% of the observed variability was due to within-person 
variability. As for the FMV collections, results were unreliable due to the negative values 
obtained. Urinary DON concentrations in FMV collections were strongly correlated with 
24-hour log-transformed data (r=0.78, p<0.0001) and moderately to strongly correlated in 
non log-transformed data (r=0.47-0.63, p<0.05), meaning urinary DON concentrations in 
FMV collections are strongly correlated with levels in same-day 24-hour collections 
when adjusted for age, sex, and BMI. Ultimately, the results of this study strengthen the 
methodology behind exposure biomarkers and urinary assays when estimating DON 
intake and show that FMV collections may provide just as reasonable of an estimate as 
24-hour collections. 
There are several limitations within this study, the first one being such a small 
population size. A larger population would provide more statistical power and strength in 
the results. Additionally, the samples were pooled, meaning the regression combined the 
first and second sample per individual for each urinary collection type. Another issue 
with the population at hand is that all participants were white Caucasian adults and 
residents of the UK, meaning that results of this study are not generalizable to other 
populations based on age, race, ethnicity, culture, and diet. It would be useful to conduct 
a pilot study to examine DON intake among different races and ethnicities because it is 
expected that age, culture, and diet play a large role in these differences. 
Another limitation is that the 24-hour collections contained a few milliliters of 
urine from the FMV collections, which may account for part of the correlation seen in the 
results. Generally, FMV collections are not ideal for assessing daily exposure because 




urinary DON concentrations in FMV collections may be just as reliable as 24-hour 
collections when estimating DON intake. More studies should be conducted to validate 
that this is true. Some of the correlation seen may also be due to potential DON intake 
from non-restricted diet sources. During the partial wheat-restriction intervention diet, 
soups and sauces were not restricted, which may be a potential source of DON, especially 
if they contained corn. Caution in this study data being applied elsewhere is also required 
in populations where the range of exposures may be higher. 
Lastly, variability and reproducibility calculations were unreliable due to the 
negative ICC values obtained from the FMV collections. Reasons for this indicate that 
the true ICC is low, but it is also possible that although most urinary DON is affected by 
the previous day (24-hours), the previous 48 hours may have affected this as well, 
suggesting that the ICC values are not absolute due to timing of consumption and timing 
of urine collection. For this reason, it is recommended that the future of this study looks 
at the relationship between timing of food consumption and urine collection and examine 























Table 1. Descriptive statistics for study population and for previous day’s bread and 
DON intake (n=13, 26 observations total (2 per individual)) 
 
Characteristic No. (%) or Mean (SD) Range 
Gender   
Male 8   
Female 5   
Age (years) 35.8 (10.0) 23.0-50 .0 
Height (m) 1.7 (0.1) 1.6-1.9 
Weight (kg) 76.5 (15.8) 61.0-108.0 
BMI (kg/m2) 25.2 (4.0) 20.2-34.1 
Bread consumed* (g)   
Total 146 (79) 0-344 
Sample 1 136 (76) 0-292 
Sample 2 148 (93) 0-344 
DON from bread* (µg/day)   
Total  12.2 (9.7) 0-36.6 
Sample 1 19.7 (27.8) 0-108.0 
Sample 2 13.0 (11.0) 0-36.6 
DON intake from bread* (ng/kg bw)   
Total  167 (136) 0-502 
Sample 1 154 (114) 0-394 
Sample 2  179 (160) 0-502 





Table 2. Descriptive statistics for DON outcome variables, unadjusted and adjusted 
for creatinine, separated by urinary collection type (n=13, 26 observations total (2 
per individual)) 
 
Sampling Type and 
Outcome Variables 
 
Mean (SD) p25 p50 p75 Max 
First Morning      
DON (ng/ml) 11.0 (9.3) 3.0 8.2 18.8 32.8 
Creatinine (mg/ml) 1.2 (0.5) 0.7 1.2 1.5 2.2 
DON/Creatinine 
(ng/mg) 
9.2 (7.1) 4.4 8.0 13.0 32.4 
24-hour      
DON (ng/ml) 11.5 (11.7) 4.0 6.4 17.4 41.0 
Creatinine (mg/ml) 1.0 (0.5) 0.6 0.8 1.3 2.1 
DON/Creatinine 
(ng/mg) 







Table 3. Intraclass Correlation Coefficients for FMV and 24-hour collections, 
unadjusted and adjusted for creatinine (n=13, 26 observations total (2 per 
individual)) 
 
Sampling Type and Outcome Variables ICC 
First Morning  
DON (ng/ml) -0.37 
DON/Creatinine (ng/mg) -0.30 
24-hour  
DON (ng/ml) 0.78 






Table 4a. Modeling of 24-hr urinary DON using FMV collections as predictors, 
adjusted for age, sex, and BMI; unadjusted and adjusted for creatinine (n=13, 26 
observations total (2 per individual))  
 
 Model type Regression model Pearson correlation 





5.9 0.63 0.0006 
Model 2 




6.2 0.63 0.0006 
Model 3 
Adjusted for creatinine 
(ng/mg) 
0.2 
(-0.02, 0.4)  




Table 4b. Modeling of log-transformed 24-hr urinary DON using FMV collections 
as predictors, adjusted for age, sex, and BMI; unadjusted and adjusted for 
creatinine (n=13, 26 observations total (2 per individual))  
 
 Model type Regression model Pearson correlation 





2.1 0.78 <0.0001 
Model 2 




2.2 0.78 <0.0001 
Model 3 
Adjusted for creatinine 
(log-ng/mg) 
0.5 
(0.2, 0.8)  
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